11 – 20 of 196
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints
2025) In European Journal of Clinical Microbiology and Infectious Diseases(
- Contribution to journal › Article
-
Mark
Low-level viremia in people with HIV in Ethiopia is associated with subsequent lack of viral suppression and attrition from care
(
- Contribution to journal › Article
-
Mark
Blood levels of Mycobacterium tuberculosis (Mtb)antigen-triggered immune markers in people exposed to tuberculosis with regard to Mtb infection status and receipt of tuberculosis preventive therapy
(
- Contribution to journal › Article
-
Mark
Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV : A RESPOND Cohort Study
(
- Contribution to journal › Article
-
Mark
Calprotectin in the risk stratification of patients with acute dyspnoea in the emergency department
(
- Contribution to journal › Article
-
Mark
Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19 : A Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Long-term recovery in critically ill COVID-19 survivors : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing Enterobacterales bloodstream infections: a retrospective, multicenter, non-inferiority, cohort study
2025) In Infection(
- Contribution to journal › Article
-
Mark
Clinical and epidemiological characteristics of Legionnaires' disease in Southern Sweden, a population-based study
(
- Contribution to journal › Article
- 2024
-
Mark
Plasma Ribonuclease Activity in Antiretroviral Treatment-Naive People With Human Immunodeficiency Virus and Tuberculosis Disease
(
- Contribution to journal › Article